Adult Autoimmune Myopathies (MAIA)

Last updated: February 4, 2025
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting

Phase

N/A

Condition

Idiopathic Inflammatory Myopathies

Myositis

Treatment

description of adult autoimmune myopathies

Clinical Study ID

NCT04792931
29BRC20.0276
  • Ages > 18
  • All Genders

Study Summary

This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Clinical suspicion of Adult Inflammatory Myopathy

  • Social security affiliation

Exclusion

Exclusion Criteria:

  • Pregnant and lactating women

  • Patients unable to consent

  • Patients refusing to participate in the research.

  • Patients under legal protection

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: description of adult autoimmune myopathies
Phase:
Study Start date:
May 20, 2022
Estimated Completion Date:
May 20, 2030

Connect with a study center

  • CHU de BREST

    Brest, 29200
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.